DrugPatentWatch Database Preview
Patent: 4,374,830
» See Plans and Pricing
Summary for Patent: 4,374,830
| Title: | Platelet aggregating material from equine arterial tissue |
| Abstract: | Novel hemostatic agent comprises equine arterial fibrillar collagen in a carrier. The agent is useful for the aggregation of platelets for clinical diagnostic tests and for the clotting of blood, such as for controlling bleeding in warm blooded species. The fibrillar collagen is obtained by extracting homogenized equine arterial tissue with aqueous solutions followed by extensive dialysis. |
| Inventor(s): | Schneider; Morris D. (Knoxville, TN) |
| Assignee: | Research Corp. (New York, NY) |
| Application Number: | 06/292,201 |
| Patent Claims: | see list of patent claims |
Details for Patent 4,374,830
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Smith And Nephew | SANTYL | collagenase | OINTMENT;TOPICAL | 101995 | 001 | 1965-06-04 | Start Trial | Research Corp. (New York, NY) | 2000-02-22 | RX | search | |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
International Patent Family for US Patent 4,374,830
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| United States of America | 4347243 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
